# ND Acquisitions Corp.: Form D filings

ND Acquisitions Corp., a pharmaceuticals company in Nashville, TN, filed 9 Form D notices with the SEC between 2009 and 2015. The latest, on March 18, 2015, reports $3.8 million sold of a $3.8 million offering to 7 investors.

Find out what ND Acquisitions Corp. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20ND%20Acquisitions%20Corp.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=ND%20Acquisitions%20Corp.&page=%2Fdata%2Fform-d%2Fcompany%2Fnd-acquisitions-corp-1464225)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20ND%20Acquisitions%20Corp.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=ND%20Acquisitions%20Corp.&page=%2Fdata%2Fform-d%2Fcompany%2Fnd-acquisitions-corp-1464225)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Tennessee](https://specstream.ai/data/form-d/state/tennessee): 543 rows, by operating companies, filed since November 1, 2024, $27.15, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/tennessee
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 5215 LINBAR DRIVE, SUITE 210, Nashville, TN, 37211
- Phone: (615) 947-2966
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1464225

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Mar 18, 2015 | New notice | $3,849,424 | $3,849,424 | $0 | 7 | Mar 10, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1464225/000146422515000001/0001464225-15-000001-index.htm) |
| Jul 2, 2014 | Amendment | $11,031,858 | $11,031,858 | $0 | 12 | Jun 11, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1464225/000146422514000001/0001464225-14-000001-index.htm) |
| Jun 28, 2013 | New notice | $10,000,000 | $8,531,859 | $1,468,141 | 12 | Jun 11, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1464225/000146422513000002/0001464225-13-000002-index.htm) |
| Jan 24, 2013 | New notice | $1,947,385 | $1,947,385 | $0 | 10 | Jan 16, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1464225/000146422513000001/0001464225-13-000001-index.htm) |
| Jul 19, 2012 | New notice | $2,000,000 | $2,000,000 | $0 | 11 | Jul 13, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1464225/000146422512000001/0001464225-12-000001-index.htm) |
| Sep 22, 2011 | New notice | $12,224,529 | $12,224,529 | $0 | 13 | Sep 9, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1464225/000146422511000001/0001464225-11-000001-index.htm) |
| Mar 10, 2011 | New notice | $5,000,000 | $5,000,000 | $0 | 5 | Feb 25, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1464225/000121005611000002/0001210056-11-000002-index.htm) |
| Oct 5, 2010 | New notice | $1,501,115 | $1,501,115 | $0 | 7 | Sep 27, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1464225/000146422510000001/0001464225-10-000001-index.htm) |
| May 21, 2009 | New notice | $5,473,606 | $5,473,606 | $0 | 6 | May 8, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1464225/000146422509000001/0001464225-09-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Dennis C. Bottorff | Director |  |
| C. Daniel Haron | Executive Officer, Director |  |
| Chris Daniel Maness | Executive Officer |  |
| Linwood A. Lacy, Jr. | Director |  |
| Kenneth M. Krakaur | Director |  |
| David A. Kaufman | Director |  |
| Mary Daniel Howard | Executive Officer |  |

[Every Form D from the week of Mar 16, 2015](https://specstream.ai/data/form-d/week/2015-03-16) · [All recent filings in Tennessee](https://specstream.ai/data/form-d/state/tennessee) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what ND Acquisitions Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).